<?xml version="1.0" encoding="UTF-8"?>
<xml>
<records>
<record>
  <contributors>
    <authors>
      <author>Dormston, W.G.P.</author>
      <author>Braathen, Lasse R.</author>
      <author>Morton , Colin A.</author>
      <author>Haedersdal, Merete</author>
      <author>Gilaberte, Yolanda</author>
      <author>Basset-Seguin, Nicole</author>
      <author>Sotiriou, Elena</author>
      <author>Wiegell,  Stine Regin</author>
      <author>Calzavara-Pinton , P.</author>
      <author>Dirschka , D.</author>
      <author>Wulf, H.C.</author>
      <author>Hofbauer , G.</author>
      <author>Szeimies, R.M.</author>
    </authors>
  </contributors>
  <titles>
    <title>Reply to “Commentary on: A European Consensus on the Consistent Use of the Term “Keratinocyte Cancer”: Keratinocyte Cancer (KC) or Keratinocyte Skin Cancer (KSC) – Does the “S” Matter?</title>
    <secondary-title>Acta derm.-venereol.</secondary-title>
  </titles>
  <doi>10.2340/actadv.v104.42287</doi>
  <pages/>
  <volume/>
  <number/>
  <dates>
    <year>2024</year>
    <pub-dates>
      <date>2024</date>
    </pub-dates>
  </dates>
  <abstract/>
</record>

</records>
</xml>